Selected article for: "median survival time and survival time"

Title: Research Communications of the 27(th) ECVIM-CA Congress: Intercontinental, Saint Julian's, Malta, 14th to 16th September 2017
  • Document date: 2017_11_7
  • ID: roslkxeq_658
    Snippet: Ten MS were diagnosed with HS during the study period, making them over-represented among the hospital population (odds ratio = 8.98 [95% CI 4.64-17.41]). Seven were diagnosed with primary pulmonary HS based on the presence of a large pulmonary mass with or without evidence of intra-thoracic metastasis or abdominal involvement, though only five exhibited overt respiratory signs. No patients had solitary HS. Five patients were treated with chemoth.....
    Document: Ten MS were diagnosed with HS during the study period, making them over-represented among the hospital population (odds ratio = 8.98 [95% CI 4.64-17.41]). Seven were diagnosed with primary pulmonary HS based on the presence of a large pulmonary mass with or without evidence of intra-thoracic metastasis or abdominal involvement, though only five exhibited overt respiratory signs. No patients had solitary HS. Five patients were treated with chemotherapy (lomustine +/epirubicin) but an aggressive clinical course was found in all patients. Median survival time of all patients was 54 days (range: 0-232 days). Several other previously reported breeds were also noted to be pre-disposed to HS.

    Search related documents:
    Co phrase search for related documents
    • clinical course and hospital population: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • clinical course and odd ratio: 1, 2
    • clinical course and patient find: 1, 2, 3
    • median patient survival time and patient survival time: 1